Login

CATALYST PHARMACEUTICALS, INC. 4 SEC Filings

Filed On Filing
17 Jul 2026 Form 4: Elsbernd Brian, Chief Legal Officer

Returned 242,501 shares to the issuer ($7.64M) · Disposed of 908,977 Options to purchase common stock (Disposition to Issuer) · Disposed of 47,165 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Curran Daniel J., Director

Disposed of 58,115 Options to purchase common stock (Disposition to Issuer) · Disposed of 5,468 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Tierney David S, Director

Returned 383,314 shares to the issuer ($12.1M) · Disposed of 169,387 Options to purchase common stock (Disposition to Issuer) · Disposed of 8,776 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Miller Steve, Chief Op. & Scientific Officer

Returned 1,093,803 shares to the issuer ($34.5M) · Disposed of 1,395,416 Options to purchase common stock (Disposition to Issuer) · Disposed of 76,233 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Thompson Tamar, Director

Returned 3,773 shares to the issuer ($119K) · Disposed of 110,887 Options to purchase common stock (Disposition to Issuer) · Disposed of 8,776 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Russo Gregg, Chief HR Officer

Returned 476 shares to the issuer ($15K) · Disposed of 62,837 Options to purchase common stock (Disposition to Issuer) · Disposed of 8,949 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Mcenany Patrick J, Director

Returned 4,171,559 shares to the issuer ($131M) · Disposed of 1,834,322 Options to purchase common stock (Disposition to Issuer) · Disposed of 17,626 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Denkhaus Donald A, Director

Returned 498,773 shares to the issuer ($15.7M) · Disposed of 169,387 Options to purchase common stock (Disposition to Issuer) · Disposed of 8,776 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Del Carmen Jeffrey, Chief Commercial Officer

Returned 14,337 shares to the issuer ($452K) · Disposed of 985,344 Options to purchase common stock (Disposition to Issuer) · Disposed of 51,502 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Sundaram Preethi, Chief Strategy Officer

Returned 54,804 shares to the issuer ($1.73M) · Disposed of 748,119 Options to purchase common stock (Disposition to Issuer) · Disposed of 50,318 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Daly Richard J, Director

Returned 271,266 shares to the issuer ($8.54M) · Disposed of 2,336,927 Options to purchase common stock (Disposition to Issuer) · Disposed of 281,612 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Andrews William T., Chief Medical Officer

Returned 2,309 shares to the issuer ($72.7K) · Disposed of 223,099 Options to purchase common stock (Disposition to Issuer) · Disposed of 41,985 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Harper Molly, Director

Returned 3,694 shares to the issuer ($116K) · Disposed of 118,387 Options to purchase common stock (Disposition to Issuer) · Disposed of 8,776 Restricted Stock Units (Disposition to Issuer)

17 Jul 2026 Form 4: Kalb Michael Wayne, Chief Financial Officer

Returned 13,665 shares to the issuer ($430K) · Disposed of 557,998 Options to purchase common stock (Disposition to Issuer) · Disposed of 74,905 Restricted Stock Units (Disposition to Issuer)

05 Jun 2026 Form 4: Andrews William T., Chief Medical Officer

Exercised 3,052 Restricted Stock Units · Received 3,052 shares by exercise or conversion · Gave up 743 shares to cover exercise price or tax

19 Feb 2026 Form 4: Russo Gregg, Chief HR Officer

Received 687 shares by exercise or conversion · Gave up 211 shares to cover exercise price or tax

06 Jan 2026 Form 4: Kalb Michael Wayne, Executive Vice President & CFO

Received 7,139 shares by exercise or conversion · Gave up 2,080 shares to cover exercise price or tax

06 Jan 2026 Form 4: Daly Richard J, Director

Received 42,105 shares by exercise or conversion · Gave up 10,577 shares to cover exercise price or tax

30 Dec 2025 Form 4: Elsbernd Brian, Chief Compliance/Legal Officer

Received 6,667 shares by exercise or conversion · Gave up 2,623 shares to cover exercise price or tax

30 Dec 2025 Form 4: Tierney David S, Director

Received 1,334 shares by exercise or conversion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support